ACADIA Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of ACADIA Pharmaceuticals (ACAD) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in ACADIA Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including ACADIA Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in ACADIA Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $9.6M | 307k | 31.31 |
| 2023-09-30 | $3.0M | 145k | 20.84 |
| 2023-06-30 | $3.3M | 140k | 23.95 |
| 2023-03-31 | $2.9M | 153k | 18.82 |
| 2022-12-31 | $5.8M | 367k | 15.92 |
| 2022-09-30 | $833k | 51k | 16.31 |
| 2022-06-30 | $477k | 34k | 14.12 |
| 2022-03-31 | $1.5M | 63k | 24.25 |
| 2021-12-31 | $5.3M | 228k | 23.30 |
| 2021-09-30 | $3.8M | 227k | 16.59 |
| 2021-06-30 | $510k | 21k | 24.44 |
| 2021-03-31 | $928k | 36k | 25.81 |
| 2020-12-31 | $2.1M | 39k | 53.46 |
| 2020-09-30 | $1.3M | 30k | 41.24 |
| 2020-06-30 | $2.6M | 54k | 48.47 |
| 2020-03-31 | $1.0M | 24k | 42.23 |
| 2019-12-31 | $8.0M | 187k | 42.78 |
| 2019-09-30 | $4.3M | 119k | 35.99 |
| 2019-06-30 | $1.6M | 59k | 26.73 |
| 2019-03-31 | $2.1M | 79k | 26.92 |
| 2018-12-31 | $4.9M | 306k | 16.17 |
| 2018-09-30 | $6.4M | 310k | 20.76 |
| 2018-06-30 | $2.7M | 178k | 15.27 |
| 2018-03-31 | $9.9M | 439k | 22.47 |
| 2017-12-31 | $6.6M | 219k | 30.00 |
| 2017-09-30 | $9.5M | 253k | 37.67 |
| 2017-06-30 | $6.8M | 245k | 27.89 |
| 2017-03-31 | $2.7M | 79k | 34.38 |
| 2016-12-31 | $5.3M | 184k | 28.84 |
| 2016-09-30 | $5.0M | 158k | 31.81 |
| 2016-06-30 | $6.1M | 188k | 32.52 |
| 2016-03-31 | $479k | 17k | 28.00 |
| 2015-12-31 | $564k | 16k | 35.60 |
| 2015-09-30 | $1.8M | 56k | 33.06 |
| 2015-03-31 | $1.5M | 49k | 30.00 |